Refine by
Drug Platform Suppliers & Manufacturers
41 companies found
based inSeongnam-si, SOUTH KOREA
Theramx Inc. was founded on the conviction that health, and the extension of life, is one of the important values that can be provided to humankind. Our company develops treatment platforms that provide the best diagnoses and treatments. As a ...
Drug delivery platform technology designed to maximize efficacy while simultaneously minimizing side effects of existing drugs by delivery to desired ...
based inSan Clemente, CALIFORNIA (USA)
Founded in 1998, Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. At Glaukos, our focus is to develop and lead the ...
based inSeattle, WASHINGTON (USA)
Lumen Bioscience discovers, develops, and manufactures biologic drug candidates for highly prevalent diseases-many of which currently lack effective treatments. The company’s unique drug development and manufacturing platform offers the potential to ...
based inNanjing, CHINA
PharmaBlock Sciences (Nanjing), Inc. (SZSE:300725) is a leading provider of innovative chemistry products and services throughout the pharmaceutical R&D process and commercial production. Its core businesses include a rationally designed building ...
based inOttawa, SWITZERLAND
Orion Biotechnology is unlocking the therapeutic potential of previously undruggable G Protein-Coupled Receptors (GPCRs) with a novel drug modality, proven discovery platform and best-in-class molecules. The company is advancing a diversified ...
G Protein-Coupled Receptors (GPCRs) are involved in a wide range of physiological and pathological processes and represent a large class of drug targets accounting for >30% of all drugs on the market. These drugs, however, only cover 15% of the ...
based inAlbuquerque, NEW MEXICO (USA)
Nob Hill Therapeutics mission is to commercialize the first of its kind dry powder nebulizer (DryNeb) inhalation drug delivery platform. NHT is focused on creating effective inhalation therapies to address lower respiratory tract infections (the 5th ...
based inThousand Oaks, CALIFORNIA (USA)
Amgen is one of the world™s leading biotechnology companies. Amgen is a values-based company, deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious illnesses. Amgen is committed to ...
based inNeedham, MASSACHUSETTS (USA)
Invicro is an integral part of the REALM IDx, Inc. group, which aims to accelerate personalized medicine, discover novel therapeutic targets and develop innovative therapeutic technologies for unmet medical needs. As a global research partner to the ...
based inTaipei, TAIWAN
Lumosa Therapeutics is a clinical-stage pharmaceutical company dedicating to develop novel therapies and solutions for neurological and oncological diseases with urgent unmet medical need. Besides of using Lumosa's own technology platform in drug ...
based inGeneva, SWITZERLAND
Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available, small molecule drugs known as allosteric modulators for neurological disorders. Allosteric ...
based inRedwood City, CALIFORNIA (USA)
Juvena Therapeutics is a biotech company accelerating the development of regenerative therapeutics by unlocking the therapeutic potential of secreted proteins. Secreted proteins are a class of biologics with proven therapeutic potential that has ...
Secreted proteins are a proven class of biologics with tremendous therapeutic potential, as they regulate tissue repair and regeneration, organ development, and immune response to disease. The characteristics of secreted proteins render them a rich ...
based inSouth San Francisco, CALIFORNIA (USA)
We are building the next enduring biotechnology company of the digital age. Verge has pioneered the industry's most advanced all-in-human, artificial intelligence powered drug discovery platform to unlock new drugs at scale for the biggest medical ...
The breadth and depth of our pipeline demonstrates the power of the ConVERGEMplatform. All pipeline programs have been discovered and developed on our proprietary platform. ...
based inGranada, SPAIN
Neuron Bio develops and manages biosolutions and projects in the biotechnological field for their application in the pharmaceutical and oleochemical industry through its subsidiaries and its specialized areas. Its pharma division is mainly devoted ...
Neuron Biolabs develops biosolutions for application in the pharmaceutical and agri-food industries through its specialised divisions. The Pharma division is dedicated fundamentally to the search for preventative drugs and treatments for ...
based inBerwyn, PENNSYLVANIA (USA)
Virpax Pharmaceuticals specializes in developing novel and proprietary drug-delivery systems across various pain and CNS disorder indications to enhance compliance and to optimize the efficacy of each product candidate. Our transforming ...
based inNangang Distric, TAIWAN
We are a clinical-stage specialty pharmaceutical company dedicated to the development and commercialization of best-in-class novel nanomedicines that combine our proprietary lipid-assembled drug delivery platform with approved active pharmaceutical ...
TLC is committed to creating solutions for longstanding challenges in drug development by enabling new therapies with entirely unique properties. TLC has proprietary solution for pharmaceutical product development called LipAD®. LipAD® ...
based inKansas City, KANSAS (USA)
Cingulate is a clinical stage biopharmaceutical company focused on the development of innovative new product candidates for the treatments of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety associated disorders. Cingulate (CTx) is a ...
Cingulate is developing ADHD medications capable of achieving precise once-daily dosing using a novel erosion based controlled release technology that provides unrivaled control of drug release. ...
based inWoburn, MASSACHUSETTS (USA)
As the scientific leader in the biological role of the microbiome gut-brain axis and its impact on neurological conditions, Axial Therapeutics is uniquely positioned to advance a fundamentally different therapeutic approach for the treatment of ...
based inGhent/Zwijnaarde, BELGIUM
Confo Therapeutics’ unparalleled technology stabilizes functional conformations of GPCRs (G protein-coupled receptors) to uncover a wide range of previously inaccessible GPCRs as drug targets. This technology platform combined with the pharmacologic ...
Confo Therapeutics is building a pipeline of drug candidates with the potential to transform therapeutic outcomes for patients with severe illnesses lacking disease-modifying ...
based inMt. Olive, NEW JERSEY (USA)
At Flowonix, our patient centric approach drives the design, development, and deployment of targeted drug delivery platforms whose sole purpose is to provide physicians an optimal solution for the treatment of their patients' numerous neurological ...
based inBrighton, UNITED KINGDOM
Destiny Pharma is a clinical phase biotechnology company dedicated to the development of novel anti-infectives with a focus on infection prevention. We have two exciting late-stage clinical assets and a range of earlier research programmes. Our ...
The XF drug platform has a novel, ultra-rapid mechanism that reduces the chance of bacteria becoming resistant to its action. Destiny Pharma’s XF platform has advantages over traditional ...